GR880100084A - Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν - Google Patents

Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν

Info

Publication number
GR880100084A
GR880100084A GR880100084A GR880100084A GR880100084A GR 880100084 A GR880100084 A GR 880100084A GR 880100084 A GR880100084 A GR 880100084A GR 880100084 A GR880100084 A GR 880100084A GR 880100084 A GR880100084 A GR 880100084A
Authority
GR
Greece
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
piperazinecarboxylic acid
abnormalities
Prior art date
Application number
GR880100084A
Other languages
English (en)
Other versions
GR1002471B (el
Inventor
Bernhard Dr Aebischer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of GR880100084A publication Critical patent/GR880100084A/el
Publication of GR1002471B publication Critical patent/GR1002471B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Πιπεράζινο καρβοξυλικό οξύ, χρήσιμο εις την αγωγήν των ανωμαλιών συνδυαζομένων με LH έκκρισιν, αυξημένον μυϊκόν τόνον, καταστάσεις συνδυαζόμενες με εγκεφαλική ισχαιμία, άγχος, κατάθλιψιν, εκφυλιστικές ανωμαλίες του ΚΝΣ, TINNITUS, επιληψία ή εις την ανακούφισιν του πόνου.ω
GR880100084A 1987-02-18 1988-02-16 Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν. GR1002471B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (2)

Publication Number Publication Date
GR880100084A true GR880100084A (el) 1988-12-16
GR1002471B GR1002471B (el) 1996-11-15

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100084A GR1002471B (el) 1987-02-18 1988-02-16 Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν.

Country Status (28)

Country Link
JP (1) JPH0723387B2 (el)
KR (1) KR960015190B1 (el)
AT (1) AT391320B (el)
AU (1) AU613009B2 (el)
BE (1) BE1002427A3 (el)
CA (1) CA1327799C (el)
CH (1) CH675125A5 (el)
CY (1) CY1739A (el)
DE (1) DE3804936C2 (el)
DK (1) DK168441B1 (el)
ES (2) ES2011319A6 (el)
FI (1) FI86733C (el)
FR (1) FR2610932B1 (el)
GB (2) GB8703749D0 (el)
GR (1) GR1002471B (el)
HK (1) HK142093A (el)
HU (2) HU199858B (el)
IE (1) IE59098B1 (el)
IL (1) IL85436A0 (el)
IT (1) IT1219447B (el)
LU (1) LU87129A1 (el)
MY (1) MY103206A (el)
NL (1) NL8800412A (el)
NZ (1) NZ223529A (el)
PH (1) PH25512A (el)
PT (1) PT86776B (el)
SE (1) SE467256B (el)
ZA (1) ZA881146B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
EP0826032A1 (de) * 1995-05-08 1998-03-04 Lonza Ag Biotechnologisches verfahren zur herstellung von r-alpha-piperazincarbonsäure und s-alpha-piperazincarbonsäureamid
HUP0100048A3 (en) 1997-05-12 2002-12-28 Ortho Mcneil Pharm Inc Arylsubstituted piperazine-derivatives, useful in the treatement of benign prostatic hyperlasia use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159889A2 (en) * 1984-04-17 1985-10-30 Btg International Limited 4-Substituted piperazine-2-carboxylic acids process and pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159889A2 (en) * 1984-04-17 1985-10-30 Btg International Limited 4-Substituted piperazine-2-carboxylic acids process and pharmaceutical compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
DE3804936C2 (de) 1997-02-13
PH25512A (en) 1991-07-24
MY103206A (en) 1993-05-29
FI880744A (fi) 1988-08-19
IL85436A (el) 1992-12-01
GB2201676B (en) 1991-01-02
FI880744A0 (fi) 1988-02-17
FR2610932A1 (fr) 1988-08-19
ES2011319A6 (es) 1990-01-01
GR1002471B (el) 1996-11-15
AU1175888A (en) 1988-08-25
ATA36788A (de) 1990-03-15
IT1219447B (it) 1990-05-18
GB2201676A (en) 1988-09-07
SE8800541D0 (sv) 1988-02-17
JPS63203691A (ja) 1988-08-23
KR880009944A (ko) 1988-10-06
PT86776B (pt) 1992-05-29
SE8800541A (el) 1988-08-19
DE3804936A1 (de) 1988-09-01
ES2021904A6 (es) 1991-11-16
GB8703749D0 (en) 1987-03-25
IE59098B1 (en) 1994-01-12
FI86733B (fi) 1992-06-30
AU613009B2 (en) 1991-07-25
BE1002427A3 (fr) 1991-02-05
KR960015190B1 (ko) 1996-11-01
HK142093A (en) 1994-01-07
DK79688A (da) 1988-08-19
HU211269A9 (en) 1995-11-28
DK168441B1 (da) 1994-03-28
CH675125A5 (el) 1990-08-31
IT8847631A0 (it) 1988-02-12
ZA881146B (en) 1989-10-25
DK79688D0 (da) 1988-02-16
PT86776A (pt) 1988-03-01
AT391320B (de) 1990-09-25
HU199858B (en) 1990-03-28
IE880413L (en) 1988-08-18
GB8803438D0 (en) 1988-03-16
NZ223529A (en) 1991-02-26
IL85436A0 (en) 1988-07-31
SE467256B (sv) 1992-06-22
NL8800412A (nl) 1988-09-16
FR2610932B1 (fr) 1990-11-16
HUT49361A (en) 1989-09-28
CA1327799C (en) 1994-03-15
JPH0723387B2 (ja) 1995-03-15
CY1739A (en) 1995-10-20
LU87129A1 (fr) 1988-09-20
FI86733C (fi) 1992-10-12

Similar Documents

Publication Publication Date Title
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
DE3381877D1 (de) Verwendung von opium antagonisten zur herstellung von arzneimitteln zur behebung gastro-intestinaler stoerungen.
IT8419645A0 (it) Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
ATE383424T1 (de) Polypeptide, deren herstellung und verwendung
IT1224867B (it) Dispositivo di supporto laterale, in particolare per l'arco mediano del piede
GR880100084A (el) Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν
IT8220410A0 (it) Filtro ceramico, procedimento per la sua fabbricazione, nonche'impiego del filtro.
NO984950L (no) Forbindelser med veksthormonfrigj°rende egenskaper
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
DE3785401D1 (de) Verwendung von phenylethanolaminen zur herstellung von arzneimitteln, wirksam fuer gastrointestinale beschwerden.
ES1012965Y (es) Conjunto del genero caja-tuerca.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
IT1204735B (it) Conca per la raffinazione del cioccolato
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
IT1194416B (it) Forma galenica del sulpiride,suo procedimento di preparazione e medicamento comprendente questa forma
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
ES8403487A1 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
DE50010972D1 (de) UBICHINON Qn ZUR BEHANDLUNG VON MIGRÄNESCHMERZEN
IT7819638A0 (it) Vite autofilettante nonche'procedimento per la sua fabbricazione e ganascia di cilindratura per l'attuazione del procedimento.
DE3866653D1 (de) Zusammensetzung fuer die behandlung der epidermis.
IT8720707A0 (it) Impiego del 2,4-monofurfuriliden-sorbitolo ad uso cosmetico.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees